Physician profile
Priya Krishna
NPI 1730153172
$20,146.82
in general payments reported to CMS, 2019-2025
8 companies · $1,712 in 2025
The $1,712 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2021: $450 · 2022: $1,682 · 2023: $10K · 2024: $5,808 · 2025: $1,712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $2,516 · Food and Beverage: $1,076 · Education: $47.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,937.50 |
| Travel and Lodging | $2,515.77 |
| Food and Beverage | $1,075.75 |
| Education | $47.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18,687.88 | 2021-2025 | Coblation, Grafix |
| Stryker Corporation | $329.28 | 2025 | Scopis Ent, N/A |
| Musculoskeletal Transplant Foundation INC. | $324.75 | 2025 | |
| Verathon INC. | $300.00 | 2019 | |
| Medtronic, INC. | $170.46 | 2024 | Signia |
| Olympus America INC. | $148.65 | 2025 | Rhino-Laryngo Videoscope, Connecting Tube |
| Covidien LP | $138.58 | 2019 | |
| Precigen, INC. | $47.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Krishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.